Stepan Company (SCL) — Fair Value Analysis

Base-case fair value (P50): $68.09 · Current price: $51.22 · Verdict: Undervalued

The Verdict on SCL

STEPAN (SCL) appears undervalued according to our latest Monte Carlo simulations, with a median fair value (P50) significantly above its current trading price. The stock is presently trading at $51.22, while our model indicates a $68.09 median fair value. This suggests a substantial +32.9% upside potential, countering any notion that SCL is currently overvalued based on these probabilistic assessments. This valuation highlights a notable disconnect between the market's current appraisal and our forward-looking intrinsic value estimates.

How SCL stacks up against peers

While the Monte Carlo simulations point to SCL being undervalued, it's important to consider its operational and financial health relative to the broader sector. STEPAN is categorized as an average quality tier company when benchmarked against its industry peers. This average quality tier suggests that while the company holds fundamental strength, its valuation upside of +32.9% from its $51.22 current price to the $68.09 median fair value is primarily driven by the probabilistic outcome of future scenarios rather than an exceptionally superior competitive position.

What this means for investors

For investors, the present valuation indicates a compelling entry point for SCL. The Monte Carlo simulations strongly suggest the stock is undervalued at $51.22, with a projected median fair value of $68.09. This +32.9% potential upside, despite an average quality tier rating, underscores a robust opportunity identified through thousands of forward-looking scenarios. To gain deeper insight into the full distribution of potential outcomes, including the detailed bear and bull case scenarios, sign up for a free FairCurve account and track SCL's fair value as new fundamentals are released.